A comparative analysis of HbA1c, glycated albumin, and fasting plasma glucose for glycemic assessment in people living with HIV.

J Microbiol Immunol Infect

Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Tropical Medicine and Infectious Disease Rese

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: People living with HIV (PLWH) are at increased risk for metabolic disorders, including diabetes and prediabetes. While hemoglobin A1c (HbA1c) is widely used for glycemic assessment, its reliability in PLWH is questioned due to altered red blood cell turnover. Glycated albumin (GA) has been proposed as an alternative, but its diagnostic utility remains unclear in PLWH. This study aims to compare the correlations of HbA1c and GA with fasting plasma glucose (FPG), evaluate their diagnostic performance, and identify factors influencing discrepancies between them in PLWH.

Methods: This retrospective cross-sectional study included 236 PLWH with documented FPG, HbA1c, and GA levels. Correlations between glycemic markers were assessed using Pearson's correlation coefficients. Diagnostic performance for prediabetes and diabetes was evaluated using receiver operating characteristic (ROC) curves, and a GA cut-off was determined using the Youden index. Multivariable logistic regression was performed to identify predictors of HbA1c-GA mismatch.

Results: HbA1c showed a moderate correlation with FPG (r = 0.33, p value < 0.001), while GA had a weaker correlation (r = 0.18, p value = 0.005). The area under the ROC curve (AUC) for detecting glycemic abnormalities was 0.66 for HbA1c and 0.57 for GA. The optimal GA cut-off for prediabetes derived from ROC analysis was 12.42 %, improving sensitivity but reducing specificity. Multivariable analysis identified low mean corpuscular volume (MCV <80 fL) as an independent predictor of HbA1c-GA mismatch (odds ratio = 4.94, 95 % confidence interval: 1.95-12.50, pvalue < 0.001).

Conclusion: HbA1c or GA alone do not reliably capture glycemic abnormalities in PLWH. A lower GA cut-off (12.42 %) for prediabetes improves sensitivity but remains suboptimal. A combined approach incorporating FPG is recommended to enhance prediabetes and diabetes screening accuracy in this population.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmii.2025.08.013DOI Listing

Publication Analysis

Top Keywords

glycated albumin
8
fasting plasma
8
plasma glucose
8
glycemic assessment
8
people living
8
living hiv
8
diagnostic performance
8
hba1c
5
comparative analysis
4
analysis hba1c
4

Similar Publications

Background: The prevalence of diabetes mellitus has surged fourfold globally over the past 30 years, creating a major health concern. Imeglimin, a novel oral antidiabetic agent, has shown promising results in the management of type 2 diabetes mellitus (T2DM).

Objectives: This systematic review aimed to evaluate the efficacy and safety of imeglimin in patients with T2DM based on available clinical studies.

View Article and Find Full Text PDF

Aim: This review aims to map the existing literature on the use of diabetes technology in people receiving dialysis, with a focus on utilization, accuracy, and effectiveness.

Methods: A scoping review was conducted using the Joanna Briggs Institute methodology, with systematic searches of Medline, Embase, and CINAHL for studies on diabetes technologies in dialysis populations.

Results: The search identified 1060 continuous glucose monitoring (CGM) and 1467 continuous subcutaneous insulin infusion or automated insulin delivery (CSII/AID) records, with 64 studies included.

View Article and Find Full Text PDF

A comparative analysis of HbA1c, glycated albumin, and fasting plasma glucose for glycemic assessment in people living with HIV.

J Microbiol Immunol Infect

August 2025

Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Tropical Medicine and Infectious Disease Rese

Background: People living with HIV (PLWH) are at increased risk for metabolic disorders, including diabetes and prediabetes. While hemoglobin A1c (HbA1c) is widely used for glycemic assessment, its reliability in PLWH is questioned due to altered red blood cell turnover. Glycated albumin (GA) has been proposed as an alternative, but its diagnostic utility remains unclear in PLWH.

View Article and Find Full Text PDF

Proliferative diabetic retinopathy (PDR) is a complication of diabetic microangiopathy that can cause severe visual impairment. Due to retinal neovascularization and fibrovascular membrane (FVM) formation, inhibition of vascularization and fibrosis plays a key role in PDR. In our study, single-cell sequencing of FVMs from PDR patients identified a MARCO microglial subpopulation exhibiting both pro-angiogenic and pro-fibrotic effects.

View Article and Find Full Text PDF

Diabetes and Cardiometabolic Care, Pharmacotherapy, and Patient Outcomes in Two Regional Aboriginal Primary Care Health Centres: Lessons to be Learnt.

Heart Lung Circ

August 2025

Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia; Endocrine and Diabetes Department, The Queen Elizabeth Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Wardliparingga Aboriginal Health Equi

Background: Type 2 diabetes mellitus (T2DM) affects Aboriginal Australian populations six times more frequently than non-Indigenous Australians, with disparity increasing by remoteness. Contemporary guidelines recommend optimising cardiometabolic care, including achieving a target glycated haemoglobin (HbA1c) <7%, blood pressure <130/80 mmHg, and use of pharmacotherapy, including the maximal tolerated statin dose and consideration of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in selected subpopulations.

Aim: This study aimed to determine whether cardiometabolic treatment targets and pharmacological management met best practice guidelines in two rural Aboriginal Community Controlled Health Organisations.

View Article and Find Full Text PDF